title: Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
abstract: BACKGROUND
  Immunoglobulin D (IgD) myeloma is a rare disease, about 2% of all myelomas, even rarer when accompanied with another multiple myeloma in biclonal gammopathy. We presented a case of biclonal gammopathy-as-sociated manifestation of IgD myeloma and light chain disease in a patient who initially had renal failure.
  
  
  METHODS
  37-year-old male approximately one month before hospitalization began to feel malaise and fatigue along with decreased urination. Laboratory analysis revealed azotemia. A dialysis catheter was placed and hemodialysis started. The patient was then admitted to our hospital for further tests and during admission, objective examination revealed pronounced paleness with hepatosplenomegaly and hypertension (170/95 mmHg). Laboratory analysis showed erythrocyte sedimentation rate 122 mm/h, expressed anemic syndrome (Hb 71 g/L) and renal failure dialysis rank: creatinine 1,408 micromol/L, urea 31.7 mmol/L. There was two M components in serum protein electrophoresis: IgD lambda and free light chain lambda. Proteinuria was nephrotic rank (5.4 g/24 h), whose electrophoresis revealed 2 M components--massive in alpha 2 fraction of 71%; 7% in the discrete beta fraction, beta 2M / serum 110 mg / L, in urine 1.8 mg/L--extremely high; IgL kappa I lambda index 1:13 (reference value ratio 2:1). The findings pointed to double myeloma disease: IgD myeloma and Bence Jones lambda myeloma. Bone biopsy confirmed IgD myeloma lambda 100% infiltration medulla predominantly plasmablasts. The treatment continued with hemodialysis 3 times per week with chemotherapy protocol bortezomib, doxorubicin, dexamethasone. After 4 cycles of chemotherapy, there was a decrease of IgD, lamda-light chains, reduction in proteinuria (1.03 g/24 h), so hemodialysis was reduced to once per week. Six months after treatment initiation the patient underwent autologous bone marrow transplantation. In a 2-year follow-up period double myeloma disease showed complete remission.
  
  
  CONCLUSIONS
  The presented rare form of double myeloma disease with initial renal insufficiency underscores the importance of careful observation and teamwork that can alter the course of this serious disease.
authors.forename: Violeta
authors.initials: V
authors.lastname: Rabrenović
authors.forename: Zoran
authors.initials: Z
authors.lastname: Mijušković
authors.forename: Slobodan
authors.initials: S
authors.lastname: Marjanović
authors.forename: Milorad
authors.initials: M
authors.lastname: Rabrenović
authors.forename: Dragan
authors.initials: D
authors.lastname: Jovanović
authors.forename: Svetlana
authors.initials: S
authors.lastname: Antić
authors.forename: Ljiljana
authors.initials: L
authors.lastname: Ignjatović
authors.forename: Milica
authors.initials: M
authors.lastname: Petrović
authors.forename: Dejan
authors.initials: D
authors.lastname: Pilcević
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology*; D000328:Adult; D006801:Humans; D007072:Immunoglobulin D / Q000097:blood*; D007146:Immunoglobulin lambda-Chains / Q000097:blood*; D008297:Male; D009101:Multiple Myeloma / Q000150:complications* / Q000276:immunology; D010265:Paraproteinemias / Q000150:complications*
chemical_list: D007072:Immunoglobulin D; D007146:Immunoglobulin lambda-Chains